Medicae usus professionalis Typhoidis Testi ornamentum, unum gradum test celeritas reta
Fusce Sensus, Specificatio et Accuracy
Influenza A+B Antigen Celeri Test probata est comparata cum RT-PCR.539 swabs nasopharyngea et swabs oropharyngea aestimata cum Influenza A+B Celeri Test.
| Substantiae | Coniunctis | Substantiae | Coniunctis |
| Nasi Spray | 15% v/v | Hemoglobin | 10% v/v |
| Mucin | 0.5 % w/v | Mupirocin | 10 mg/mL |
| Nasi Guttae | 15% v/v | Mouthwash | / |
| Chloraseptic | 1.5 mg/mL | Levofloxacin | 40 ug/mL |
| Oseltamivir | 2ug/mL | Ribavirin | 0.2ug/mL |
| Fluticasone propionate | 5% v/v | Ceftriaxone | 800 ug/mL |
| Tobramycin | 4ug/mL | Salina Nasi Spray | 10% v/v |
For Influenza A
| Methodus | RT-PCR | Summa Proventuum | ||
| Influenza A+B Rapid Test | Proventus | Positivum | Negative | |
| Positivum | 116 | 1 | 117 | |
| Negative | 5 | 417 | 422 | |
| Summa Proventuum | 121 | 418 | 539 | |
Orci sensibilitatem：95.87% (95% CI: 90.69%~ 98.22%)
Fusce specificity：99.76% (95% CI: 98.66%~99.96%)
Totalis coincidentia rate：98.89% (95% CI: 97.59%~99.49%).
For Influenza B;
| Methodus | RT-PCR | Summa Proventuum | ||
| Influenza A+B Rapid Test | Proventus | Positivum | Negative | |
| Positivum | 97 | 1 | 98 | |
| Negative | 6 | 435 | 441 | |
| Summa Proventuum | 103 | 436 | 539 | |
Orci sensus：94.17% (95% CI: 87.87%~ 97.30%)
Fusce specificity：99.77% (95% CI: 98.71%~99.96%)
Totalis coincidentia rate：98.70% (95% CI: 97.34%~99.37%).
Analytica Sensibilitas / LOD
 | Hangzhou Aichek Medical Technology CO, Ltd. Jinxing Cun, Yuhang Community, Yuhang Districtus (Future Sci-Tech urbs), Hangzhou, Zhejiang, PR China |
 | SANGO Europa BV Olympisch Stadion 24, 1076DE Amstelodami, Nederland |
Terminus deprehensionis (LOD) idem est aestimans diversas concentrationes influenza A virus et influenza B virus in Influenza A+B Antigen Celeri Test.Concentraciones notantur sicut gradus LOD probati infra recensentur.
Influenza A (H3N2): 5×103 TCID50/mL
Influenza A (H1N1): 2.5×103 TCID50/mL
Influenza A (H1N1 pdm09): 2.5×103 TCID50/mL
Influenza B (Yamagata): 3.5×103 TCID50/mL
Influenza B (Victoria): 1.0×103 TCID50/mL
Analytica Specificatio (Crux Reactividad)
Determinare analyticam specificitatem Influentiae A+B Antigen Celeri Test, complures microorganismi commensales vel pathogenicos, qui in tractu respiratorii superiori adesse probati sunt.
Specimina positiva et negativa cum his microbes spicatae aestimatae sunt ad collationem 106 TCID50/mL, inter SARS-CoV-2, Coronavirus Humani HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumovirus, Parainfluenza, respiratorium. syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis, Haemophilus influenzae, Streptococcus pyogenes.Nulla crux reactivitatis visa est cum Influenza A+B Antigen Test.
INTENTUM USUM
Influenza A+B Antigen Testium celeris est fluxus lateralis immunoassay destinatus ad detectionem qualitivam influenzam A et influenza B antigens in swab nasopharyngea et swab oropharyngea.
Company Commodum
1.Professional Manufacturer, nationalis-gradus technologice provectus "gigans" inceptum
2.Deliver bona ut ordo petitionem
3.ISO13485, CE Praeparate varia documenta shipping
4.Reply customers quaestiones in XXIV horas
